Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
7.71
+0.22 (3.01%)
At close: Dec 4, 2025, 4:00 PM EST
7.55
-0.16 (-2.01%)
After-hours: Dec 4, 2025, 7:53 PM EST
Quanterix Revenue
Quanterix had revenue of $40.23M in the quarter ending September 30, 2025, with 12.34% growth. This brings the company's revenue in the last twelve months to $130.20M, down -2.69% year-over-year. In the year 2024, Quanterix had annual revenue of $137.42M with 12.30% growth.
Revenue (ttm)
$130.20M
Revenue Growth
-2.69%
P/S Ratio
2.40
Revenue / Employee
$276,439
Employees
471
Market Cap
359.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 137.42M | 15.05M | 12.30% |
| Dec 31, 2023 | 122.37M | 16.85M | 15.96% |
| Dec 31, 2022 | 105.52M | -5.03M | -4.55% |
| Dec 31, 2021 | 110.56M | 24.18M | 27.99% |
| Dec 31, 2020 | 86.38M | 29.64M | 52.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
QTRX News
- 14 days ago - Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth - Business Wire
- 17 days ago - Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring - Business Wire
- 24 days ago - Quanterix Corporation (QTRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Quanterix Releases Financial Results for the Third Quarter of 2025 - Business Wire
- 4 weeks ago - Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025 - Business Wire
- 3 months ago - Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit - Business Wire
- 4 months ago - Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 4 months ago - Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript - Seeking Alpha